Cell-based studies revealed that UBCS039 activates SIRT6 and decreased H3K9 and H3K56 acetylation levels in various cancer cell lines such as NSCLC, fibrosarcoma, colon and epithelial cervix carcinoma [100]. This evidence concerns the gene SIRT6 and non-small cell lung carcinoma.